Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review

A. Clegg, J. Bryant, T. Nicholson, L. McIntyre, S. de Broe, K. Gerard, Norman Robert Waugh

Research output: Contribution to journalArticle

111 Citations (Scopus)
Original languageEnglish
JournalHealth Technology Assessment
Volume5
Issue number1
Publication statusPublished - 2001

Cite this

Clegg, A., Bryant, J., Nicholson, T., McIntyre, L., de Broe, S., Gerard, K., & Waugh, N. R. (2001). Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Health Technology Assessment, 5(1).

Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. / Clegg, A.; Bryant, J.; Nicholson, T.; McIntyre, L.; de Broe, S.; Gerard, K.; Waugh, Norman Robert.

In: Health Technology Assessment, Vol. 5, No. 1, 2001.

Research output: Contribution to journalArticle

Clegg, A, Bryant, J, Nicholson, T, McIntyre, L, de Broe, S, Gerard, K & Waugh, NR 2001, 'Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review', Health Technology Assessment, vol. 5, no. 1.
Clegg, A. ; Bryant, J. ; Nicholson, T. ; McIntyre, L. ; de Broe, S. ; Gerard, K. ; Waugh, Norman Robert. / Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. In: Health Technology Assessment. 2001 ; Vol. 5, No. 1.
@article{737ce440425b47ba8cee3eba7d39a71a,
title = "Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review",
author = "A. Clegg and J. Bryant and T. Nicholson and L. McIntyre and {de Broe}, S. and K. Gerard and Waugh, {Norman Robert}",
year = "2001",
language = "English",
volume = "5",
journal = "Health Technology Assessment",
issn = "1366-5278",
publisher = "National Co-ordinating Centre for HTA",
number = "1",

}

TY - JOUR

T1 - Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review

AU - Clegg, A.

AU - Bryant, J.

AU - Nicholson, T.

AU - McIntyre, L.

AU - de Broe, S.

AU - Gerard, K.

AU - Waugh, Norman Robert

PY - 2001

Y1 - 2001

M3 - Article

VL - 5

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 1

ER -